Considering TRIP13 induced treatment resistance by interacting with NHEJ proteins KU70/KU80/DNA-PKcs and its inhibitor DCZ0415 impaired NHEJ 15, 19, we speculated that the combination of DCZ0415 and Olaparib increased the inhibition level of HCC. Here, PRKDC is linked to hepatocellular carcinoma.